lysine has been researched along with Hypertension, Renal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T | 1 |
| Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H | 1 |
| Aizawa, T; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Nangaku, M; Tominaga, N; van Ypersele de Strihou, C | 1 |
| Asawa, T; Komiya, I; Nishimori, T; Shimabukuro, M; Takara, M; Takasu, N; Yamada, T | 1 |
| Georgiev, P; Iurukova, Ts | 1 |
1 trial(s) available for lysine and Hypertension, Renal
| Article | Year |
|---|---|
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome | 2012 |
4 other study(ies) available for lysine and Hypertension, Renal
| Article | Year |
|---|---|
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles | 2003 |
Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biopsy, Needle; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renal; Immunohistochemistry; In Vitro Techniques; Kidney; Lysine; Male; Rats; Rats, Inbred SHR; Sensitivity and Specificity; Statistics, Nonparametric | 2005 |
Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension.
Topics: Adult; Aged; Aldosterone; Alleles; Arginine; Cytochrome P-450 CYP11B2; DNA Mutational Analysis; Female; Gene Expression Regulation, Enzymologic; Genetic Markers; Humans; Hypertension, Renal; Japan; Lysine; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Renin; Renin-Angiotensin System | 2000 |
[Arterial scleroproteins in atherosclerosis and hypertension (experimental studies)].
Topics: Animals; Aorta; Arteriosclerosis; Collagen; Elastin; Hypertension; Hypertension, Renal; Lysine; Proline; Protein Biosynthesis; Rats; Rats, Inbred Strains | 1979 |